Fundz

Elite Pharmaceuticals Elects Two New Directors

PUBLIC · ELTPNov 03, 2026

Position

Director

Company

Elite Pharmaceuticals

John W. LaRocca, Esq.
NorthvaleManufacturingBiotechnologyHealthcarePharmaceutical

Description

On October 28, 2026, Elite Pharmaceuticals, Inc. appointed Aqeel A. Fatmi, Ph.D., and John W

Who to call at Elite Pharmaceuticals, and when

A new leader at Elite Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Elite Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elite Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elite Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elite Pharmaceuticals

Location

Northvale, New Jersey, United States

About

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals (“ECR”), a wholly owned subsidiary of Hi-Tech Pharmacal (“Hi-Tech”). Elite’s lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elite Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Carter
Likely contact at this company
••••••••@••••••••

See Carter's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Elite Pharmaceuticals's next move

Learn about Strategic plan

Elite Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.